vs
NATURES SUNSHINE PRODUCTS INC（NATR）とRapid7, Inc.（RPD）の財務データ比較。上の社名をクリックして会社を切り替えられます
Rapid7, Inc.の直近四半期売上が大きい（$217.4M vs $123.8M、NATURES SUNSHINE PRODUCTS INCの約1.8倍）。NATURES SUNSHINE PRODUCTS INCの純利益率が高く（3.3% vs 1.4%、差は1.9%）。NATURES SUNSHINE PRODUCTS INCの前年同期比売上増加率が高い（4.7% vs 0.5%）。Rapid7, Inc.の直近四半期フリーキャッシュフローが多い（$36.4M vs $7.6M）。過去8四半期でNATURES SUNSHINE PRODUCTS INCの売上複合成長率が高い（5.6% vs 3.0%）
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
Rapid7社は世界的に有名なサイバーセキュリティ企業で、脆弱性管理、脅威検知・対応、クラウドセキュリティ、セキュリティ分析などの総合的なソリューションを提供しています。テクノロジー、医療、金融、製造業などの各業種の企業や公共部門を顧客とし、サイバー脅威への効率的な対応を支援します。
NATR vs RPD — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $123.8M | $217.4M |
| 純利益 | $4.1M | $3.1M |
| 粗利率 | 72.5% | 68.9% |
| 営業利益率 | 4.3% | 1.0% |
| 純利益率 | 3.3% | 1.4% |
| 売上前年比 | 4.7% | 0.5% |
| 純利益前年比 | 1379.4% | 44.1% |
| EPS（希薄化後） | $0.23 | $0.05 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $123.8M | $217.4M | ||
| Q3 25 | $128.3M | $218.0M | ||
| Q2 25 | $114.8M | $214.2M | ||
| Q1 25 | $113.2M | $210.3M | ||
| Q4 24 | $118.2M | $216.3M | ||
| Q3 24 | $114.6M | $214.7M | ||
| Q2 24 | $110.6M | $208.0M | ||
| Q1 24 | $111.0M | $205.1M |
| Q4 25 | $4.1M | $3.1M | ||
| Q3 25 | $5.3M | $9.8M | ||
| Q2 25 | $5.3M | $8.3M | ||
| Q1 25 | $4.7M | $2.1M | ||
| Q4 24 | $-321.0K | $2.2M | ||
| Q3 24 | $4.3M | $15.4M | ||
| Q2 24 | $1.3M | $6.5M | ||
| Q1 24 | $2.3M | $1.4M |
| Q4 25 | 72.5% | 68.9% | ||
| Q3 25 | 73.3% | 70.2% | ||
| Q2 25 | 71.7% | 70.6% | ||
| Q1 25 | 72.1% | 71.7% | ||
| Q4 24 | 72.0% | 69.5% | ||
| Q3 24 | 71.3% | 70.6% | ||
| Q2 24 | 71.4% | 70.7% | ||
| Q1 24 | 71.2% | 70.3% |
| Q4 25 | 4.3% | 1.0% | ||
| Q3 25 | 7.0% | 2.7% | ||
| Q2 25 | 3.7% | 1.6% | ||
| Q1 25 | 5.4% | -0.0% | ||
| Q4 24 | 3.8% | 3.4% | ||
| Q3 24 | 4.6% | 6.0% | ||
| Q2 24 | 5.1% | 2.5% | ||
| Q1 24 | 4.2% | 4.7% |
| Q4 25 | 3.3% | 1.4% | ||
| Q3 25 | 4.2% | 4.5% | ||
| Q2 25 | 4.6% | 3.9% | ||
| Q1 25 | 4.2% | 1.0% | ||
| Q4 24 | -0.3% | 1.0% | ||
| Q3 24 | 3.8% | 7.2% | ||
| Q2 24 | 1.2% | 3.1% | ||
| Q1 24 | 2.1% | 0.7% |
| Q4 25 | $0.23 | $0.05 | ||
| Q3 25 | $0.30 | $0.15 | ||
| Q2 25 | $0.28 | $0.13 | ||
| Q1 25 | $0.25 | $0.03 | ||
| Q4 24 | $-0.02 | $0.08 | ||
| Q3 24 | $0.23 | $0.21 | ||
| Q2 24 | $0.07 | $0.09 | ||
| Q1 24 | $0.12 | $0.02 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $93.9M | $474.7M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $161.6M | $154.7M |
| 総資産 | $261.1M | $1.7B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $93.9M | $474.7M | ||
| Q3 25 | $95.6M | $407.1M | ||
| Q2 25 | $81.3M | $511.7M | ||
| Q1 25 | $86.5M | $493.5M | ||
| Q4 24 | $84.7M | $521.7M | ||
| Q3 24 | $78.7M | $443.7M | ||
| Q2 24 | $68.7M | $442.6M | ||
| Q1 24 | $77.8M | $411.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $154.7M | ||
| Q3 25 | $166.7M | $127.2M | ||
| Q2 25 | $163.7M | $90.4M | ||
| Q1 25 | $167.1M | $52.7M | ||
| Q4 24 | $161.0M | $17.7M | ||
| Q3 24 | $162.6M | $-5.1M | ||
| Q2 24 | $156.4M | $-52.6M | ||
| Q1 24 | $159.7M | $-86.4M |
| Q4 25 | $261.1M | $1.7B | ||
| Q3 25 | $264.8M | $1.7B | ||
| Q2 25 | $254.9M | $1.6B | ||
| Q1 25 | $252.7M | $1.6B | ||
| Q4 24 | $240.9M | $1.7B | ||
| Q3 24 | $245.3M | $1.6B | ||
| Q2 24 | $235.8M | $1.5B | ||
| Q1 24 | $247.3M | $1.5B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $9.9M | $37.6M |
| フリーキャッシュフロー営業CF - 設備投資 | $7.6M | $36.4M |
| FCFマージンFCF / 売上 | 6.1% | 16.8% |
| 設備投資強度設備投資 / 売上 | 1.9% | 0.5% |
| キャッシュ転換率営業CF / 純利益 | 2.41× | 12.01× |
| 直近12ヶ月FCF直近4四半期 | $28.8M | $146.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $9.9M | $37.6M | ||
| Q3 25 | $18.5M | $39.0M | ||
| Q2 25 | $4.3M | $47.5M | ||
| Q1 25 | $2.6M | $29.8M | ||
| Q4 24 | $12.2M | $63.8M | ||
| Q3 24 | $9.6M | $44.0M | ||
| Q2 24 | $1.3M | $32.9M | ||
| Q1 24 | $2.2M | $31.1M |
| Q4 25 | $7.6M | $36.4M | ||
| Q3 25 | $16.8M | $34.8M | ||
| Q2 25 | $3.0M | $46.6M | ||
| Q1 25 | $1.5M | $28.4M | ||
| Q4 24 | $10.0M | $62.6M | ||
| Q3 24 | $7.9M | $42.6M | ||
| Q2 24 | $-2.0M | $32.6M | ||
| Q1 24 | $-1.5M | $30.4M |
| Q4 25 | 6.1% | 16.8% | ||
| Q3 25 | 13.1% | 16.0% | ||
| Q2 25 | 2.6% | 21.8% | ||
| Q1 25 | 1.3% | 13.5% | ||
| Q4 24 | 8.5% | 28.9% | ||
| Q3 24 | 6.9% | 19.9% | ||
| Q2 24 | -1.9% | 15.7% | ||
| Q1 24 | -1.4% | 14.8% |
| Q4 25 | 1.9% | 0.5% | ||
| Q3 25 | 1.3% | 1.9% | ||
| Q2 25 | 1.2% | 0.4% | ||
| Q1 25 | 1.0% | 0.6% | ||
| Q4 24 | 1.9% | 0.5% | ||
| Q3 24 | 1.5% | 0.6% | ||
| Q2 24 | 3.0% | 0.1% | ||
| Q1 24 | 3.3% | 0.3% |
| Q4 25 | 2.41× | 12.01× | ||
| Q3 25 | 3.46× | 3.97× | ||
| Q2 25 | 0.81× | 5.70× | ||
| Q1 25 | 0.55× | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | 2.21× | 2.85× | ||
| Q2 24 | 0.97× | 5.03× | ||
| Q1 24 | 0.94× | 22.10× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
